ArticleBMJ open2020

Effect of spironolactone on cardiovascular morbidity and mortality in patients with hypertension and glucose metabolism disorders (ESCAM): a study protocol for a pragmatic randomised controlled trial.

Nanfang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.